Abstract

Murine cytomegalovirus (mCMV) codes for MHC class-I trafficking modulators m04/gp34, m06/gp48, and m152/gp40. By interacting with the MHC class-Iα chain, these proteins disconnect peptide-loaded MHC class-I (pMHC-I) complexes from the constitutive vesicular flow to the cell surface. Based on the assumption that all three inhibit antigen presentation, and thus the recognition of infected cells by CD8 T cells, they were referred to as “immunoevasins.” Improved antigen presentation mediated by m04 in the presence of m152 after infection with deletion mutant mCMV-Δm06W, compared to mCMV-Δm04m06 expressing only m152, led us to propose renaming these molecules “viral regulators of antigen presentation” (vRAP) to account for both negative and positive functions. In accordance with a positive function, m04-pMHC-I complexes were found to be displayed on the cell surface, where they are primarily known as ligands for Ly49 family natural killer (NK) cell receptors. Besides the established role of m04 in NK cell silencing or activation, an anti-immunoevasive function by activation of CD8 T cells is conceivable, because the binding site of m04 to MHC class-Iα appears not to mask the peptide binding site for T-cell receptor recognition. However, functional evidence was based on mCMV-Δm06W, a virus of recently doubted authenticity. Here we show that mCMV-Δm06W actually represents a mixture of an authentic m06 deletion mutant and a mutant with an accidental additional deletion of a genome region encompassing also gene m152. Reanalysis of previously published experiments for the authentic mutant in the mixture confirms the previously concluded positive vRAP function of m04.

Highlights

  • Human cytomegalovirus is the prototype member of the ß-subfamily of the herpesviruses [for an overview, see Davison et al (2013)]

  • To investigate the reason for the unexpectedly diminished m152 expression in cells infected with murine cytomegalovirus (mCMV)- m06W (Fink et al, 2012, 2013; Lemmermann et al, 2012) we tested the genetic authenticity of this mutant in comparison to mCMV-WT.BAC and the independently generated mutant mCMV- m06L (Fink et al, 2012) by full-length genome next-generation sequencing (NGS) of purified virion DNA

  • The sequencing revealed a large deletion in mCMV- m06W (Figure 1B) spanning ≈13 kbp encompassing 14 open reading frame (ORF) from m145 to m158, many of which code for MHC-Iv glycoproteins that have been associated with modulation of host innate and/or adaptive immunity

Read more

Summary

Introduction

Human cytomegalovirus (hCMV) is the prototype member of the ß-subfamily of the herpesviruses [for an overview, see Davison et al (2013)]. As experimental approaches and studies with recombinant viruses carrying targeted mutations for addressing mechanistic questions are not feasible in clinical investigations, the mouse model based on infection with murine cytomegalovirus (mCMV) has been developed as a versatile preclinical model. It has already provided “proof of principle” for basic aspects of viral pathogenesis and immune control, including cytoimmunotherapy with antiviral CD8 T cells in HCT recipients (Krmpotic et al, 2003; Reddehase, 2016; Reddehase and Lemmermann, 2018; Renzaho et al, 2020). The host species-specific CMVs differ in many genes involved in host adaptation, co-speciation of hosts and their respective CMVs has led to biological convergence in fundamental principles of virus-host interaction

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call